Transcriptomic Profiling Reveals Antifibrotic effect of Cannabidiol through Epithelial/Endothelial-to-Mesenchymal Transition inhibition in a Murine Non-Ischemic Heart Failure Model
We Recommend
Disclosures
<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Abiomed</li><li>Grant Support/Research Contract - CVRx; Cardiol Therapeutics</li></ul>